Impact of cetirizine on the burden of allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 5, 1999, Pages 455-463

  Meltzer, Eli O ^a   Grant, J Andrew ^b  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGIC RHINITIS; HUMAN; MORTALITY; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0032754179     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62851-7     Document Type: Article

References (85)

1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
2. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-7.
3. Meltzer E. Comparative safety of antihistamines. Ann Allergy 1991;67: 625-33.
4. Spector SL. Overview of the comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99:S773-80.
5. Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol 1997;99:S787-97.
6. Harvey RP, Comer C, Sanders B, et al. Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97:1233-41.
7. Nathan RA, Meltzer EO, Selner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:S808-14.
8. Bergmann RL, Bergmann KE, Lau-Schadensdorf S, et al. Atopic diseases in infancy. The German multicentre atopy study (MAS-90). Paedr Allergy Immunol 1994;5(Suppl 1):19-25.
9. Storms W, Meltzer EO, Nathan RA, Selner JC. The economic impact of allergic rhinitis. J Allergy Clin Immunol 1997;99:S820-4.
10. Meltzer EO. The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:S805-28.
11. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.
12. Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:309-16.
13. Meltzer EO, Nathan RA, Selner JC, Storms W. Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 1997;99:S815-9.
14. Storms W, Meltzer EO, Nathan RA, Selner JC. Allergic rhinitis: the patient's perspective. J Allergy Clin Immunol 1997;99:S825-8.
15. Holgate S, Church MK, eds. Allergy. London: Gower Medical Publishing, 1993.
16. Horak F, Berger U, Toth J, et al. The placebo controlled effect of cetirizine 10 mg (CTZ) on rhinoconjunctivitis as objectivated by conjunctival digital imaging (CDI) and patient symptom scores. Ann Allergy Asthma Immunol 1997;78:126.
17. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children in mite-allergic asthma. Int Arch Allergy Immunol 1996;109: 272-6.
18. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997;99:S781-6.
19. Ciprandi G, Buscaglia S, Pesce G, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995; 95:612-21.
20. Boone M, et al. Adhesion molecules profiles in the skin of atopic dermatitis and of allergic contact dermatitis before and after patch testing. Pharmacological modulation by cetirizine. Poster, European Contact Dermatitis Symposium Rotterdam, 1996.
21. Wüttrich B. Epidemiology and natural history of atopic dermatitis. Allergy Clin Immunol Int 1996;8:77-82.
22. Asher MI, Keil U, Anderson HR, Beasley R, et al. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-91.
23. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15(1):21-5.
24. Spector SL, Nicodemus CF, Corren J, et al. Comparison of bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995;96: 174-81.
25. Simons FE, McMillan JL, Simons KJ. A double-blind, single dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole and chlorpheniramine versus placebo: suppressive effects of histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;86:540-7.
26. 1-receptor antagonists. Clin Exp Allergy 1996;26:1092-7.
27. Sannita WG, Crimi E, Riela S, et al. Cutaneous antihistaminic action of cetirizine and dose-related EEG concomitants of sedation in man. Eur J Pharmacol 1996;300:33-41.
28. Fadel R, Herpin-Richard N, Dufresne F, Rihoux JP. Pharmacological modulation by cetirizine and loratadine of antigen and histamine-induced skin wheals and flares and late accumulation of eosinophils. J Int Med Res 1990;18:366-71.
29. Gengo FM, Dabronzo J, Yurchak A, et al. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther 1987; 42:265-72.
30. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94:427-38.
31. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2 HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
32. 1-antihistamines. J Amer Acad Derm 1991;24:1094-6.
33. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clinical Allergy 1987;17: 373-9.
34. Fadel R, David B, Herpin-Richard N, et al. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man. J Allergy Clin Immunol 1990;86:314-20.
35. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
36. Redier H, Chanez P, De Vos C, et al. Inhibitory effect on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
37. Cheria-Sammari S, Aloui R, Gormand F, et al. Leukotriene B4 production by blood neutrophils in allergic rhinitis-effects of cetirizine. Clin Exp Allergy 1995;25:729-36.
38. Atkins PC, Zweiman B, Moskovitz A, et al. Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: effects of cetirizine. J Allergy Clin Immunol 1997; 99:806-11.
39. Taborda-Barata L, Jacobson M, Walker S, et al. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996;26: 68-78.
40. Tillement JP, Albengres E. Can one adjust the distribution of a drug in an organism to its target sites? The example of antihistaminics (anti-H1) and cetirizine. Allergie Immunol 1996;28:330-2.
41. 1-receptor antagonists. An EAACI position paper. Allergy 1996;51: 666-75.
42. Wood SG, John BA, Chasseaud LF, et al. The metabolism and pharmacokinetics of 14C-cetirizine in humans. Ann Allergy 1987;59:31-4.
43. Data on file, UCB.
44. Hulhoven R, et al. Lack of clinically relevant interaction of cetirizine on theophylline disposition in healthy subjects: A placebo-controlled study. Am J Ther 1994;1:1-4.
45. Sale M, Woosley R, Thakker K, et al. Effects of cetirizine and erythromycin alone and in combination on QT interval and pharmacokinetics in healthy subjects. Ann Allergy Asthma Immunol 1996;64:93.
46. Sale M, Woosley R, Thakker K, et al. A randomised, placebo-controlled multiple-dose study to evaluate the electrocardiographic and pharmacokinetic interactions of azithromycin and cetirizine. Ann Allergy Asthma Immunol 1996;64:93.
47. Patat A, Stubbs D, Dunmore C, et al. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects. Eur J Clin Pharmacol 1995;48:143-50.
48. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance and EEG during driving. Eur J Clin Pharmacol 1992;42:363-9.
49. Doms M, Vanhulle G, Baelde Y, et al. Lack of potentiation by cetirizine of alcohol-induced psychomotor disturbances. Eur J Clin Pharmacol 1988;34: 619-23.
50. Van Peer A, Crabbé R, Woestenborghs R, et al. Ketoconazole inhibits loratadine metabolism in man. Allergy 1993; 48(Suppl 16):34.
51. Sale ME, Barbey JT, Woosley RL, et al. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994;56:295-301.
52. Vuurman EFP, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 1993;71:121-6.
53. Gengo F. Dilemma: antihistamine selection: use vs side effects. J S Pharmacist 1990;59-68;70,92.
54. Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991; 66:257-62.
55. Cetirizine, US package insert.
56. 1-antagonists: evaluation methods and experimental results. Allergol Immunopathol 1993;21:79-83.
57. 1-receptor antagonists in allergic disease. New York: Marcel Dekker, 1996:357-82.
58. Moser L, Huther KJ, Koch-Weser J, Lundt PV. Effects of terfenadine and d diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings. Eur J Clin Pharmacol 1978; 14:417-23.
59. Seppala T, Nuotto E, Korttila K. Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep. Br J Clin Pharmacol 1981;12: 179-88.
60. Nicholson AN. Effects of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man. Br J Clin Pharmacol 1979;8:321-4.
61. Goetz DW, Jacobson JM, Apaliski SJ, et al. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991;67: 448-54.
62. Kulshrestha VK, Gupta PP, Turner P, Wadsworth J. Some clinical pharmacological studies with terfenadine, a new antihistamine drug. Br J Clin Pharmacol 1978;6:25-9.
63. Goetz DW, Jacobson JM, Murnane JE, et al. Prolongation of simple and choice reaction time in a double-blind comparison of twice daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989;84:316-22.
64. Volkerts ER. Does cetirizine belong to the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness. J Hum Psychopharmacol 1992;7:227-38.
65. Volkerts ER, van Laar M. Specific review of the psychometric effects of cetirizine. Allergy 1995;50:55-60.
66. Gengo F, Gabos C. Antihistamines, drowsiness and psychomotor impairment: central nervous system effect of cetirizine. Ann Allergy 1987; 59:53-7.
67. Gengo FM, Gabos C, Mechtler L. Quantitative effects of cetirizine and diphenhydramine on mental performances measured using an automobile driving simulator. Ann Allergy 1990; 64:520-6.
68. Seidel WF, Cohen S, Bliwise NG, Dement WC. Cetirizine effects on objective measures of daytime sleepiness and performance. Ann Allergy 1987; 59:58-62.
69. Levander S, Stähle-Bäckdahl M, Hägermark Ö. Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol 1991;41:435-9.
70. 1-receptor antagonists. Clin Exp Allergy 1996;26:1092-7.
71. Hindmarch I, Sherwood N, Mariz S, Burtin B. A comparison of the effects of cetirizine and loratadine on human psychomotor activity. Abstract 227, XV International Congress of Allergology and Clinical Immunology, June 26-July 1, 1994, Stockhom, Sweden.
72. Schweitzer PK, Muehlbach MJ, Walsh JK. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 1994;94:716-24.
73. O'Hanlon J, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 1995;50:234-42.
74. Rombaut NEI, Hindmarch I. Psychometric aspects of antihistamines: a review. Hum Psychopharmacol 1994;9: 157-69.
75. Einarson A, Bailey B, Jung G, et al. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997; 78:183-6.
76. Schatz M, Petitti D. Antihistamines and pregnancy. Ann Allergy Asthma Immunol 1997;78:157-9.
77. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine or placebo in subjects with seasonal allergic rhinitis (SAR): effects upon controlled ragweed pollen challenge in an environmental exposure unit. Ann Allergy Asthma Immunol 1997;78:126.
78. Frossard N, Lacronique J, Melac M, et al. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with seasonal allergic rhinitis. Allergy 1997;52(2):205-9.
79. Day JH, Briscoe MP, Clark RH, et al. Onset of action and efficacy of terfenadine, astemizole, cetirizine and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:163-72.
80. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97: 617-26.
81. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:371-5.
82. Lockey RF, Widlitz MD, Mitchell DQ, et al. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1996;76:448-54.
83. 1-receptor antihistamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 1993;91:1005-14.
84. 1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. J Allergy Clin Immunol 1993;91:1189-97.
85. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.